Drug establishment licences and COVID-19 (English, HTML)

View metadata and access the original English HTML file: Drug establishment licences and COVID-19.

Format
HTML
Access
file-only
Publisher-reported update
2020-08-28

All Canadian drug establishments must have a drug establishment licence to fabricate, package/label, distribute, import, wholesale or test a drug as required under Part C, Division 1A of the Food and Drug Regulations.

Access original file

Data overview

Formats
HTML
File languages
English
Available actions
Access original file

Official sources and licences

Related open data